IGF2BP3 and hepatocellular carcinoma: It was obvious that HCC patients with higher mRNA levels of YTHDF1, YTHDF2, IGF2BP1, IGF2BP2, IGF2BP3, HNRNPC, NKAP displayed shorter overall survival (OS) time (Figure 6).